Burke Valerie, Beilin Lawrie J, Cutt Hayley E, Mansour Jacqueline, Wilson Amy, Mori Trevor A
University of Western Australia, School of Medicine and Pharmacology, Royal Perth Hospital Unit and West Australian Institute for Medical Research, Perth, Australia.
J Hypertens. 2005 Jun;23(6):1241-9. doi: 10.1097/01.hjh.0000170388.61579.4f.
To assess effects of multifactorial lifestyle modification on antihypertensive drug needs in treated hypertensive individuals.
Randomized controlled trial.
Research studies unit.
Overweight hypertensive patients, receiving one or two antihypertensive drugs, were recruited by advertising, and allocated randomly to a usual care group (controls; n = 118) or a lifestyle modification group (programme group; n = 123).
A 4-month programme of weight loss, a low-sodium 'Dietary Approaches to Stop Hypertension'-type diet with added fish, physical activity and moderation of alcohol intake. After 4 months, if mean 24-h ambulatory blood pressure (ABP) was less than 135/85 mmHg, antihypertensive drugs were withdrawn over 4 weeks and long-term home blood pressure monitoring was begun.
Antihypertensive drug requirements, ABP, weight, waist girth at 4 months and 1-year follow-up.
Ninety control group and 102 programme group participants completed the study. Mean 24-h ABP changed after 4 months by -1.0/-0.3 +/- 0.5/0.4 mmHg in controls and -4.1/-2.1 +/- 0.7/0.5 mmHg with the lifestyle programme (P < 0.01). At follow-up, changes in the two groups were not significantly different (4.1/1.3 +/- 1.1/1.0 mmHg in controls; 2.5/-0.1 +/- 1.1/0.8 mmHg in the programme group; P = 0.73). At 4 months, drug withdrawal differed significantly between the groups (P = 0.038) in men (control 44%; programme 66%) but not in women (65 and 64%, respectively; P = 0.964). At follow-up, sex-related differences were not significant, and 41% in the control group and 43% in the programme group maintained drug-withdrawal status. With the programme, net weight loss was 3.3 kg (P < 0.001) at 4 months and 3.0 kg (P < 0.001) at follow-up; respective net decreases in waist girth were 3.3 cm (P < 0.001) and 3.5 cm (P < 0.001).
A 4-month multifactorial lifestyle modification in patients with treated hypertension reduced blood pressure in the short-term. Decreased central obesity persisted 1 year later and could reduce overall cardiovascular risk.
评估多因素生活方式改变对已接受治疗的高血压患者降压药物需求的影响。
随机对照试验。
研究单位。
通过广告招募超重高血压患者,这些患者正在接受一种或两种降压药物治疗,随机分为常规护理组(对照组;n = 118)或生活方式改变组(干预组;n = 123)。
进行为期4个月的减肥计划,采用低钠的“终止高血压饮食疗法”类型饮食并添加鱼类,进行体育活动以及适度饮酒。4个月后,如果24小时动态血压(ABP)平均值低于135/85 mmHg,则在4周内逐渐停用降压药物并开始长期家庭血压监测。
4个月及1年随访时的降压药物需求、ABP、体重、腰围。
90名对照组参与者和102名干预组参与者完成了研究。4个月后,对照组24小时ABP平均变化为-1.0/-0.3±0.5/0.4 mmHg,生活方式干预组为-4.1/-2.1±0.7/0.5 mmHg(P<0.01)。随访时,两组变化无显著差异(对照组为4.1/1.3±1.1/1.0 mmHg;干预组为2.5/-0.1±1.1/0.8 mmHg;P = 0.73)。4个月时,两组男性患者的药物停用情况有显著差异(P = 0.038)(对照组44%,干预组66%),但女性无差异(分别为65%和64%;P = 0.964)。随访时,性别相关差异不显著,对照组41%和干预组43%维持药物停用状态。通过该干预计划,4个月时体重净减轻3.3 kg(P<0.001),随访时为3.0 kg(P<0.001);腰围分别净减少3.3 cm(P<0.001)和3.5 cm(P<0.001)。
对已接受治疗的高血压患者进行为期4个月的多因素生活方式改变可在短期内降低血压。1年后中心性肥胖减轻持续存在,可降低总体心血管风险。